Research Directory

How PARP inhibitors prevent the survival of cancers

Read more

Pharmacovigilance is at a crossroads

Read more

Trends in investment for cell and gene therapies

Read more

Achieving federated analysis through partnership, by Philip Quinlan

Read more

New opportunities awaited travellers to San Francisco

Read more

How Astex built a business on fragment-based discovery

Read more

Destiny Pharma advances strategy against bacteria

Read more

J.P. Morgan goes virtual

Read more

A new paradigm for gene therapy

Read more

Hot targets in immuno-oncology

Read more